Medications & Supplements/Prescription Drugs

Verapamil Extended-Release Tablets Recalled for Failed Dissolution Testing

Agency Publication Date: April 14, 2023

Summary

American Health Packaging is recalling 695 cartons of Verapamil Hydrochloride Extended-Release Tablets (180 mg) because the medication failed dissolution testing by dissolving faster than specified. This recall affects generic Verapamil, a medication used to treat high blood pressure and chest pain, which was distributed nationwide. While no injuries or illnesses have been reported to date, patients should consult their doctor or pharmacist if they have concerns about their medication.

Risk

When an extended-release medication dissolves too quickly, it can cause the drug to enter the bloodstream faster than intended, potentially leading to an overdose or increased risk of side effects like low blood pressure or an irregular heartbeat.

What You Should Do

This recall affects Verapamil Hydrochloride Extended-Release Tablets (USP, 180 mg) sold in 100-count cartons containing 10-count unit dose strips under the American Health Packaging brand.
Check your medication packaging for NDC codes 60687-504-01 (Carton) or 60687-504-11 (Unit Dose) and look for lot numbers 1008622 or 1010026 with an expiration date of 2/29/24.
If you have health concerns about this medication, contact your healthcare provider or pharmacist immediately.
Return any unused medication to the place of purchase for a refund, throw it away, or contact American Health Packaging or Amerisource Health Services LLC for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Verapamil Hydrochloride Extended-Release Tablets, USP (180 mg)by American Health Packaging

Variants: 180 mg, Extended-Release, Tablet

Lot Numbers:

1008622 (Exp 2/29/24)

1010026 (Exp 2/29/24)

NDC:

60687-504-01

60687-504-11

100 Tablets (10 x 10) per carton; barcode (01) 003 60687 504 11 7.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 91956

Status: Resolved

Manufacturer: Amerisource Health Services LLC

Sold By: American Health Packaging

Manufactured In: United States

Units Affected: 695 cartons

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Verapamil Hydrochloride Extended-Release Tablets (USP, 180 mg) sold in 100-count cartons containing 10-count unit dose strips under the American Health Packaging brand.

Check your medication packaging for NDC codes 60687-504-01 (Carton) or 60687-504-11 (Unit Dose) and look for lot numbers 1008622 or 1010026 with an expiration date of 2/29/24.

If you have health concerns about this medication, contact your healthcare provider or pharmacist immediately.

Return any unused medication to the place of purchase for a refund, throw it away, or contact American Health Packaging or Amerisource Health Services LLC for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.